scholarly journals Perinatal Exposure to a High-Fat Diet Is Associated with Reduced Hepatic Sympathetic Innervation in One-Year Old Male Japanese Macaques

PLoS ONE ◽  
2012 ◽  
Vol 7 (10) ◽  
pp. e48119 ◽  
Author(s):  
Wilmon F. Grant ◽  
Lindsey E. Nicol ◽  
Stephanie R. Thorn ◽  
Kevin L. Grove ◽  
Jacob E. Friedman ◽  
...  
Endocrinology ◽  
2011 ◽  
Vol 152 (8) ◽  
pp. 3049-3061 ◽  
Author(s):  
Jie Wei ◽  
Yi Lin ◽  
Yuanyuan Li ◽  
Chenjiang Ying ◽  
Jun Chen ◽  
...  

2021 ◽  
Vol 270 ◽  
pp. 116243
Author(s):  
Axelle Brulport ◽  
Ludovic Le Corre ◽  
Guillaume Maquart ◽  
Virginie Barbet ◽  
Aurélie Dastugue ◽  
...  

Endocrinology ◽  
2010 ◽  
Vol 151 (6) ◽  
pp. 2603-2612 ◽  
Author(s):  
Karen K. Ryan ◽  
April M. Haller ◽  
Joyce E. Sorrell ◽  
Stephen C. Woods ◽  
Ronald J. Jandacek ◽  
...  

Bisphenol-A (BPA) is an endocrine-disrupting chemical used in the production of plastic food and beverage containers, leading to ubiquitous low-dose human exposure. It has been suggested that exposure to even low doses of BPA during development may be associated with increased susceptibility to obesity and diabetes later in life. Despite growing public concern, the existing empirical data are equivocal, prompting The Endocrine Society, the National Institute of Environmental Health Sciences, and others to call for further research. In this study, we tested the hypothesis that perinatal exposure to an ecologically relevant dose of BPA (1 part per billion via the diet) results in increased susceptibility to high-fat diet-induced obesity and glucose intolerance in adult CD-1 mice. The data did not support this hypothesis. In agreement with previous reports, we find that weanling mice exposed to BPA during gestation and lactation are heavier compared with control mice. We also find that BPA mice are longer than controls at 4 wk of age, but these differences are no longer apparent when the mice reach adulthood, even when tested on a high-fat diet. We conclude that this larger size-for-age represents a faster rate of growth early in development rather than an obese, diabetic phenotype in adulthood.


2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Sumit Bhattacharyya ◽  
Leo Feferman ◽  
Terry Unterman ◽  
Joanne K. Tobacman

Aims. Major aims were to determine whether exposure to the commonly used food additive carrageenan could induce fasting hyperglycemia and could increase the effects of a high fat diet on glucose intolerance and dyslipidemia.Methods. C57BL/6J mice were exposed to either carrageenan, high fat diet, or the combination of high fat diet and carrageenan, or untreated, for one year. Effects on fasting blood glucose, glucose tolerance, lipid parameters, weight, glycogen stores, and inflammation were compared.Results. Exposure to carrageenan led to glucose intolerance by six days and produced elevated fasting blood glucose by 23 weeks. Effects of carrageenan on glucose tolerance were more severe than from high fat alone. Carrageenan in combination with high fat produced earlier onset of fasting hyperglycemia and higher glucose levels in glucose tolerance tests and exacerbated dyslipidemia. In contrast to high fat, carrageenan did not lead to weight gain. In hyperinsulinemic, euglycemic clamp studies, the carrageenan-exposed mice had higher early glucose levels and lower glucose infusion rate and longer interval to achieve the steady-state.Conclusions. Carrageenan in the Western diet may contribute to the development of diabetes and the effects of high fat consumption. Carrageenan may be useful as a nonobese model of diabetes in the mouse.


2021 ◽  
pp. 113518
Author(s):  
Jessica Frayre ◽  
Priscila Frayre ◽  
Ida Wong ◽  
Anusha Mithani ◽  
Stephanie Bishop ◽  
...  

2013 ◽  
Vol 74 (3) ◽  
pp. 252-258 ◽  
Author(s):  
Melissa A. Suter ◽  
Diana Takahashi ◽  
Kevin L. Grove ◽  
Kjersti M. Aagaard

2011 ◽  
Vol 93 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Elinor L. Sullivan ◽  
M. Susan Smith ◽  
Kevin L. Grove

2014 ◽  
Vol 222 (3) ◽  
pp. 313-325 ◽  
Author(s):  
Jie Wei ◽  
Xia Sun ◽  
Yajie Chen ◽  
Yuanyuan Li ◽  
Liqiong Song ◽  
...  

Bisphenol A (BPA) is one of the environmental endocrine disrupting chemicals, which is present ubiquitously in daily life. Accumulating evidence indicates that exposure to BPA contributes to metabolic syndrome. In this study, we examined whether perinatal exposure to BPA predisposed offspring to fatty liver disease: the hepatic manifestation of metabolic syndrome. Wistar rats were exposed to 50 μg/kg per day BPA or corn oil throughout gestation and lactation by oral gavage. Offspring were fed a standard chow diet (SD) or a high-fat diet (HFD) after weaning. Effects of BPA were assessed by examination of hepatic morphology, biochemical analysis, and the hepatic expression of genes and/or proteins involved in lipogenesis, fatty acid oxidation, gluconeogenesis, insulin signaling, inflammation, and fibrosis. On a SD, the offspring of rats exposed to BPA exhibited moderate hepatic steatosis and altered expression of insulin signaling elements in the liver, but with normal liver function. On a HFD, the offspring of rats exposed to BPA showed a nonalcoholic steatohepatitis-like phenotype, characterized by extensive accumulation of lipids, large lipid droplets, profound ballooning degeneration, impaired liver function, increased inflammation, and even mild fibrosis in the liver. Perinatal exposure to BPA worsened the hepatic damage caused by the HFD in the rat offspring. The additive effects of BPA correlated with higher levels of hepatic oxidative stress. Collectively, exposure to BPA may be a new risk factor for the development of fatty liver disease and further studies should assess whether this finding is also relevant to the human population.


Sign in / Sign up

Export Citation Format

Share Document